Recurrent Vulvovaginal Candidiasis: An Immunological Perspective.

Area of Science:

• Immunology
• Microbiology
• Gynecology

Background:

• Vulvovaginal candidiasis (VVC) affects up to 75% of women, with recurrent VVC (RVVC) impacting 9% of women.
• RVVC diminishes quality of life and increases healthcare costs.
• Historically, VVC was attributed to weakened host defenses against Candida.

Purpose of the Study:

• To review the current understanding of the host immune response in VVC pathogenesis.
• To explore the role of the fungus-host-microbiota interplay in VVC.

Main Methods:

• Literature review of recent research on VVC and RVVC.
• Analysis of immune system reactions to Candida albicans colonization.
• Examination of the interaction between fungi, host, and microbiota.

Main Results:

• Emerging evidence suggests VVC pathogenesis may involve a local mucosal immune overreaction.
• A dysregulated immune response, rather than immune deficiency, is increasingly implicated in RVVC.
• The interplay between Candida, the host immune system, and the vaginal microbiota is crucial.

Conclusions:

• The understanding of VVC pathogenesis is shifting from host defense failure to immune system overreaction.
• A balanced fungus-host-microbiota interaction is vital for preventing recurrent Candida infections.
• Further research into immune modulation could offer new therapeutic strategies for RVVC.